Definition of targetable signaling pathways in chronic lymphocytic leukemia patients with rationale to novel therapy with EZH2 inhibition
2018/31/N/NZ5/03344
Keywords
Descriptors
- NZ5_7: Leczenie chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym
Voivodeship: lubelskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 16 – announced on 2018-09-14
- Amount awarded
- 210 000 PLN
- Project start date
- 2019-08-12
- Project end date
- 2025-08-11
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.